International Clinical Trial: Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07645430) titled 'Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib' on June 9.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Benha University

Condition: Alopecia Areata

Intervention: Drug: Baricitinib 4 MG Oral Tablet

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: January 1, 2023

Target Sample Size: 20

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07645430

Published by HT Digi...